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Angiogenesis is a process of new blood vessel formation. Inhibition of angiogenesis 
is considered one of the most promising strategies in treating variety of illnesses 
including cancer. Labisia Pumila var. alata (Myrsiaceae) or locally known as ‘kacip 
fatimah’, a lowland plant, is used widely by the Malays in Peninsular Malaysia to 
treat many health problems and ailments. A literature search did not reveal any 
reports of its anti-angiogenesis activity. To date this is the first study on anti-
angiogenesis activity of Labisia pumila. The aim of this study was to investigate 
anti-angiogenesis activity, anti-oxidant properties, total phenolic content and 
chemical constituents of Labisia pumila leaves extracts and fractions. The plant was 
pulverized and extracted successively with petroleum ether (PE), chloroform (CE), 
methanol (ME) and water (WE). The anti-angiogenesis activity of different extracts 
(PE, CE, ME and WE) of Labisia pumila leaves was studied using rat aortic ring 
assay. The study showed that Labisia pumila leaves extracts significantly inhibited 
microvessels outgrowth of extracts. The methanolic extract gave the most 
significant anti-angiogenesis activity (P<0.05).  This extract was further fractionated 
into three fractions, ethyl acetate fraction (EAF), n-hexane fraction (NF) and water 
fraction (WF). WF had the highest anti-angiogenesis level, which was lower than 
the level of the methanol extract (ME). These two samples were found to be non-
cytotoxic in the MTT assay against human umbilical vein endothelial cells 
(HUVEC). Both samples showed no significant cytotoxic activity towards selected 
cancer cell lines.  ME and WF were also found to inhibit the endothelial tube 
formation in the HUVEC tube formation assay. Labisia pumila methanol extract and 
water fraction demonstrated the inhibition of VEGF protein expression level. Owing 
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to the importance of anti-oxidants in angiogenesis, both extract and fraction were 
analysed for their free radical scavenging activity that revealed their potent anti-
oxidative properties. The anti-oxidant property was analyzed using DPPH (1, 1–
diphenyl-2-picrylhydrazyl) assay and the total phenolic assay was analyzed by 
Folin-Ciocalteau method. The results demonstrated that methanol extract and water 
fraction of this plant had potent anti-oxidant activity as observed in the DPPH 
assays with IC50 of the extract and fraction determined to be 0.4021µg/ml and 
0.4060µg/ml respectively. The total phenolic content of 1mg of the plant leaves 
extract and fraction is equivalent to 18µg gallic acid. The chemical constituents of 
this plant extract and fraction were determined using FTIR, GCMS and LCMS-TOF 
techniques. LCMS-TOF analysis on ME and WF showed the presence of vitamin 
D3 derivatives with ME having significant amounts of 4-phatlimidoglutaramic acid, 
which were absent in the WF fraction. In conclusion, the current study suggests that 
Labisia pumila methanol extract and water fraction may potentially act as potent 
angiogenesis inhibitor. This activity may be due to the presence of the two 






Angiogenesis merupakan suatu proses pembentukan pembuluh darah baru. 
Penghalangan angiogenesis merupakan strategi yang penting dalam rawatan pelbagai 
penyakit termasuk kanser. Labisia pumila var alata (Myrsiaceae) atau lebih dikenali 
dengan nama tempatannya sebagai ‘kacip fatimah’ merupakan tumbuhan di tanah 
rendah lazimnya digunakan secara meluas oleh penduduk Melayu di Semenanjung 
Malaysia dalam rawatan pelbagai penyakit di negara ini. Tiada sebarang kajian 
literasi yang melaporkan aktiviti anti-angiogenesis bagi tumbuhan ini. Oleh yang 
demikian, kajian ini merupakan kajian pertama bagi melaporkan aktiviti anti-
angiogenesis bagi Labisia pumila. Tujuan kajian ini adalah untuk mengkaji aktiviti 
anti-angiogenesis, kandungan anti-oksidan, jumlah kandungan fenol dan juga unsur-
unsur bahan kimia yang terdapat dalam Labisia pumila. Tumbuhan ini pada mulanya 
dipotong kecil dan dikisar serta kemudian di ekstrak secara berperingkat dengan eter 
petroleum (PE), khlorofom (CE), methanol (ME) dan air (WE). Cerakin angiogenesis 
telah dijalankan dengan menggunakan ekstrak-ekstrak Labisia pumila yang berbeza 
ini (PE, CE, ME dan WE). Keputusan kajian yang diperolehi menunjukkan bahawa 
pertumbuhan pembuluh darah telah direncatkan dengan rawatan oleh sampel-sampel 
ini. Ekstrak metanol didapati merupakan ekstrak yang terbanyak bersifat anti-
angiogenesis berbanding yang lain dengan kebarangkalian P<0.05. Kelompok ini 
dipecahkan lagi kepada tiga fraksi iaitu fraksi etil asetat (EAF), fraksi n-heksana 
(NF) dan fraksi air (WF). WF menunjukkan tahap anti-angiogenesis yang tinggi 
tetapi berada pada tahap yang lebih rendah daripada ekstrak ME. Kedua-dua sampel 
ini telah didapati tidak sitotoksik dalam cerakinan MTT pada sel-sel endothelium 
vena umbilicus manusia (human umbilical vein endothelial cells (HUVEC) dan juga 
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pada sel-sel kanser manusia yang di pilih dalam kajian ini. ME dan WF juga 
menunjukkan perencatan dalam cerakinan pembentukan tiub HUVEC dan ekspresi 
protein VEGF. Berdasarkan kepada kepentingan anti-oksidan dalam anti-
angiogenesis, aktiviti pencarian radikal bebas bagi kedua-dua sampel telah dianalisa. 
Kandungan anti-oksidan bagi ME dan WF dikaji dengan menggunakan cerakin 1,1-
diphenyl-2-picrylhydrazyl (DPPH). Cerakin jumlah fenol juga dianalisa bagi kedua-
dua sampel ini dengan menggunakan kaedah Folin-Ciocalteau. Keputusan yang 
diperolehi menunjukkan bahawa ekstrak metanol dan fraksi air bagi tumbuhan ini 
menunjukkan sifat anti-oksidan yang baik sepertimana diperhatikan dalam cerakin 
DPPH iaitu dengan IC50 yang diperolehi bagi ekstrak metanol dan fraksi air masing-
masing adalah 0.4021µg/ml dan0.4060µg/ml. Jumlah kandungan fenol bagi 1mg 
estrak dan fraksi ini adalah bersamaan dengan 18µg asid galik. Unsur-unsur kimia 
bagi ekstrak dan fraksi tumbuhan ini telah diperolehi dengan menggunakan teknik 
FTIR, GCMS dan LCMS-TOF. Dalam analisa menggunakan teknik LCMS-TOF 
pada ME dan WF, kehadiran vitamin D3 dan asid phtalimidoglutaramic telah 
dikenalpasti. Asid phtalimidoglutaramic hanya terdapat pada ME tetapi tidak pada 
WF. Kesimpulannya, kajian ini telah mencadangkan bahawa ekstrak metanol dan 
fraksi air bagi Labisia pumila berkemungkinan bertindak sebagai perencat 
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1.1 Natural Products of Medicinal Value 
 
Malaysia’s biodiversity is rich in natural resources. Today, out of more than 20,000 
species of angiosperms (flowering plant) and 600 species of ferns in Malaysia, 1,082 
species of angiosperm and 76 species of fern have been documented to have medicinal 
properties (Noor Rain et al., 2007). It has been reported that among 25 best selling 
medicines in the world, 30% of it are derived from natural products (Kong et al., 2003). 
  
In our study, we have chosen to work on Labisia pumila, a popular plant in Malaysia 
that has been used as a herbal remedy to treat various common ailments and to maintain 
overall good health.  Natural products are a preferable choice nowadays. Numbers of 
known natural products are being developed rapidly because of its potential in 
discovering new treatment of several illnesses (Alves and Rosa, 2007). Apart from that, 
medicines derived from natural products or herbal medicines which contain bioactive 
pytochemical constituents plays a vital role in a physiological action on human body 




Throughout the whole world, almost 3 billion people depend on herbal remedies as 
sources of medicines (Mahady, 2001). Figure 1.1 demonstrates the use of natural 
products as sources of new drugs between years 1981-2002. 
 
The idea of particular plants to be used and the methods of application to cure particular 
ailments were passed from generation to generation mainly through oral history (Joshi 
et al., 2004). 
 
As the potential of plant based medicines is far from exhausted, biological and 
phytochemical screenings are rapidly being conducted by researchers to find new drugs 




Figure 1.1 The use of natural product as sources of new drugs in 1981-2002 (Newman 






























Medicinal Agent Plant 
Acetyldigoxin Digitalis lanata Ehrh. 
BerberineVincristine and Vinblastine Berberis vulgaris L. 
CurcuminQuinidine Curcuma longa L. 
Digitoxin Digitalis purpurea L. 
Ephedrine Ephedra sinica Stapf 
Hyoscamine Hyoscamus niger L. 
Morphine Papaver somniferum L. 
Pseudoephedrine Ephedra sinica Stapf 
Quinine Cinchona ledgeriana Moens ex. Trimen 
Rhomitoxin Rhododendron molle G. Don 
Salicin Salix alba L. 
